Skip to main content

Day: November 14, 2023

Morbark Showcases Power Solutions International’s Products at TCI 2023

PSI’s gas and electric power units to be on display alongside Morbark equipment at Worlds Largest Tree Care Show WOOD DALE, Ill., Nov. 14, 2023 (GLOBE NEWSWIRE) — Power Solutions International, Inc. (“PSI” or “the Company”) (OTC Pink: PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, announced Morbark, a well-known leader in manufacturing tree care equipment, will feature several of its products during TCI Expo 2023. Morbark will display PSI’s new 30kw lithium-ion power unit as well as two of its chipper models in Booth 1611 during the show, which takes place Nov. 16 through 18 in the America’s Center Convention Complex, 701 Convention Plaza, St. Louis, Mo. The chipper models being featured during the show include models from Morbark’s new BVR brush chipper line, the BVR10,...

Continue reading

Akoustis to Attend the 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023

Charlotte, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that founder and CEO Jeff Shealy will attend the 14th Annual Craig-Hallum Alpha Select Conference being held at the Sheraton New York Times Square Hotel on November 16, 2023. Investors that would like to schedule a meeting with Akoustis management should contact their Craig-Hallum representative or Akoustis’ investor relations at ir@akoustis.com. Akoustis maintains its momentum with robust demand and an expanding sales pipeline for its XBAW® filter products, in addition to its new XBAW®/SAW resonator and oscillator products, and semiconductor back-end...

Continue reading

AIM ImmunoTech Announces Publication of Data from Roswell Park Comprehensive Cancer Center Phase 1 Study Evaluating Ampligen® as a Component of a Chemokine-Modulating (CKM) Regimen in Metastatic Triple-Negative Breast Cancer

Data published in The Journal for ImmunoTherapy of Cancer OCALA, Fla., Nov. 14, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of results from the Phase 1 study at Roswell Park Comprehensive Cancer Center in patients with metastatic triple-negative breast cancer using chemokine modulation therapy, including AIM ImmunoTech Inc.’s drug candidate Ampligen® (also known as rintatolimod), interferon α-2b and celecoxib, followed by pembrolizumab. The data were published in a manuscript titled, “Systemic Infusion of TLR3-Ligand and IFNα in Breast Cancer Patients Reprograms Local Tumor Microenvironment for Selective CTL Influx,” in The Journal for ImmunoTherapy of Cancer. The pilot study evaluated the safety of systemic CKM composed of intravenous rintatolimod (Ampligen;...

Continue reading

FreshPure Waters Expands Its National Footprint with Acquisition of Arctic Mountain Premium Drinking Water

FreshPure Waters Hydration StationFreshPure Waters is extending its presence nationwide with its acquisition of Arctic Mountain, providing the cleanest drinking water solutions while reducing environmental waste through superior refillable bulk water options.Santa Fe, New Mexico, Nov. 14, 2023 (GLOBE NEWSWIRE) — FreshPure Waters (“FreshPure”) is reaffirming its position as a leading national brand with the strategic acquisition of Pure Water Technologies, operating as Arctic Mountain, a prominent water vending solutions provider based in Salt Lake City, Utah. This milestone marks a significant step in FreshPure’s journey towards sustained growth and establishes a strong presence in 42 states, with a growing network of dispensing systems in grocery stores. Chris Donnelly, President of FreshPure, commented on the acquisition,...

Continue reading

Successful RC Drill Program Completed at Nunyerry North

RC Drilling Commenced at BecherFigure 1Novo’s Pilbara tenure showing priority prospects, joint venture interests and the location of drilling at Nunyerry North and Becher.Figure 2Nunyerry North coarse gold in white translucent quartz veins from surface.Figure 3Nunyerry North geological interpretation and drill hole location plan.Figure 4Nunyerry North long section (looking NNW) showing m x g/t Au (downhole width) for the Main Lode #1Figure 5Nunyerry North cross sections 590860E looking WSW.Figure 6Nunyerry North cross section 590660E (looking WSW).Figure 7The broader Nunyerry North Project area highlighting contoured gold results from soil sampling at Nunyerry North and completed RC drill holesHIGHLIGHTSContinued exploration success in the Egina Gold Camp, Novo’s highly...

Continue reading

Reading International Reports Third Quarter 2023 Results

Cinema Business Continues Strong ReboundBest Third Quarter Total Revenue, Operating Income & Adjusted EBITDA Since Q4 2019U.S. Real Estate Sets Highest Third Quarter Revenue Ever Earnings Call Webcast to Discuss Third Quarter Financial Results Scheduled to Post to Corporate Website on Thursday, November 16, 2023 NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) — Reading International, Inc. (NASDAQ: RDI) (the “Company”), an internationally diversified cinema and real estate company with operations and assets in the United States, Australia, and New Zealand, today announced its results for the third quarter ended September 30, 2023. President and Chief Executive Officer, Ellen Cotter said, “Building on the success of our strong second quarter, the Company continued that positive momentum into the third quarter by delivering global total...

Continue reading

Seanergy Maritime Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2023 and Declares Dividend of $0.025 Per Share

Highlights          (in million USD, except EPS)   Q3 2023 Q3 2022 9M 2023 9M 2022Net Revenues   $24.5 $34.0 $70.8 $96.5Net (loss) / income   ($5.0) $7.1 ($8.5) $16.7Adjusted net (loss) / income1   ($2.6) $7.6 $0.5 $22.4EBITDA1   $7.1 $18.6 $27.9 $47.6Adjusted EBITDA1   $9.5 $19.0 $29.1 $53.3           (Loss) / earnings per share Basic1,2   ($0.28) $0.41 ($0.48) $0.96(Loss) / earnings per share Diluted1,2   ($0.28) $0.40 ($0.48) $0.94Adjusted (loss) / earnings per share Basic1,2   ($0.14) $0.43 $0.02 $1.29Adjusted (loss) / earnings per share Diluted1,2   ($0.14) $0.42 $0.02 $1.26           Other Highlights and Developments:Fleet Time Charter Equivalent (“TCE” 3) overperformance of Baltic Capesize Index (“BCI”) by 14% in 3Q23 & by 18% in 9M23 Consistent quarterly cash dividend of $0.025 per...

Continue reading

Trupanion’s Holiday Safety Guide: Protecting Your Pets During Festive Seasons

SEATTLE, Nov. 14, 2023 (GLOBE NEWSWIRE) — The holiday season, a period synonymous with joy, merriment, and family gatherings, also presents unique challenges for our beloved pets. As we immerse ourselves in festive activities, Trupanion, the leading provider of pet medical insurance for cats and dogs, aims to shed light on the unique safety considerations for our furry companions during this season. Pet Health Insights from Trupanion   The holiday season, with its added decorations, foods, and presents, invites a world of wonder for our curious pets. As the parties roll in, feasts are laid out, and gifts are wrapped, the allure of new sights and scents can lead them into mischief. Analysis of Trupanion’s data from over 10 million veterinary invoices received over the last 20 years, underscores the importance of being attentive...

Continue reading

SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients’ Brand Chewables

CHINO HILLS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced: SOHM OTC Self-care launches a suite of 13 new SOHM Nutrients’ Brand Chewables. SOHM OTC Self-care business unit is launching its suite of 13 new SOHM Nutrients’ Brand Chewables into the global vitamin gummies market. The global vitamins market is valued at $6.84 billion in 2022 and is expected to reach $18.76 billion by 2031 with a CAGR of 12.06% between 2023-2031. (CAGR, Compounded Annual Growth Rate.) Source:  Link to Insight ACE Analytics report 2022 Research and Markets report noted the drivers for the explosive growth of the global vitamin gummies include: — Global consumers...

Continue reading

Performance Shipping Inc. Announces the Sale of 2007 Built M/T P. Kikuma for US$39.3 Million

ATHENS, Greece, Nov. 14, 2023 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG), (“we” or the “Company”), a global shipping company specializing in the ownership of tanker vessels, announced today that it has signed, through a separate wholly-owned subsidiary, a Memorandum of Agreement to sell the 2007-built Aframax tanker vessel M/T P. Kikuma to an unaffiliated third party, for a gross sale price of US$39.3 million. Delivery to the buyer is scheduled for December 2023. The Company expects to record a gain on the sale of the M/T P. Kikuma of approximately US$17.3 million during the fourth quarter of 2023, excluding any commissions and transaction-related costs. Commenting on the sale, Andreas Michalopoulos, the Company’s Chief Executive Officer, stated: “During this year Aframax tanker values appreciated significantly,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.